It will be important to design future studies to determine which HDL compositional and structural changes underlie the loss of function that contributes to Alzheimer’s disease pathology and how APOE genotype shapes these processes, so that potential therapeutic strategies to improve HDL functionality can be tested for their effectiveness in the prevention or treatment of cognitive decline. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.